IIM
CPRX

INTECH Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History

INTECH Investment Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Buy
94,087
+37,709
+67% +$1.11M 0.03% 556
2026
Q1 		$1.4M Sell
56,378
-13,069
-19% -$311K 0.01% 856
2025
Q4 		$1.62M Buy
69,447
+15,034
+28% +$335K 0.01% 855
2025
Q3 		$1.07M Sell
54,413
-46,656
-46% -$960K 0.01% 1123
2025
Q2 		$2.19M Buy
101,069
+30,982
+44% +$731K 0.02% 710
2025
Q1 		$1.7M Buy
70,087
+4,261
+6% +$96K 0.02% 859
2024
Q4 		$1.37M Buy
65,826
+33,431
+103% +$718K 0.01% 934
2024
Q3 		$644K Buy
+32,395
New +$601K 0.01% 1082

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

INTECH Investment Management's CPRX Position: Q2 2026 in Review

INTECH Investment Management increased its Catalyst Pharmaceutical (CPRX) stake by 67% in Q2 2026, buying an estimated $1.11M and bringing the position to 94,087 shares worth $2.96M. The position accounts for 0.03% of the portfolio, ranked #556.

INTECH Investment Management first reported a position in CPRX in Q3 2024 and has held it in 8 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • INTECH Investment Management held 94,087 shares of Catalyst Pharmaceutical worth $2.96M as of Q2 2026.
  • INTECH Investment Management bought 37,709 Catalyst Pharmaceutical shares in Q2 2026, an estimated $1.11M.
  • Catalyst Pharmaceutical made up 0.03% of INTECH Investment Management's portfolio in Q2 2026, its #556 holding.
  • INTECH Investment Management first reported a position in Catalyst Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.